JPMorgan sees another 20% upside in Regeneron shares: this is why

Shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) have already gained about 25% since early September but a JPMorgan analyst is convinced the stock will continue to move up in the coming months. ...

CytomX Shares Jump After Cancer Therapy Pact With Pharma Major Regeneron

CytomX Therapeutics Inc (NASDAQ: CTMX) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced a collaboration and licensing agreement to create conditionally-activated bispecific cancer therapies....

GameStop, Rivian, Regeneron, Snap and more

Pedestrians pass in front of a GameStop retail store in New York, December 23, 2021. Scott Mlyn | CNBC Check out the companies making headlines in midday trading Thursday. GameStop – Shares of video g...

WHO Backs Merck’s Antiviral Pill For High-Risk Covid Patients But Finds Regeneron’s Antibody Cocktail ‘Ineffective’ Against Omicron

Topline The World Health Organization has recommended Merck’s molnupiravir to treat high-risk Covid patients, the agency announced Thursday, the first oral antiviral it has endorsed though availabilit...

Regeneron beats fourth-quarter estimates | Invezz

Regeneron (NASDAQ: REGN) recorded $23.72 EPS in the fourth quarter, which topped the $18.37 analyst estimates by $5.35. In addition, the company reported $4.95 billion in revenue in the same quarter, ...